How does probenecid affect tigecycline elimination?
Probenecid can change tigecycline elimination because it inhibits renal tubular secretion pathways that help clear certain drugs. Tigecycline is eliminated partly through non-renal routes, but its overall clearance can still be influenced by changes in transporter activity. If probenecid blocks key transport-mediated clearance steps, tigecycline exposure may increase (slower elimination).
Does probenecid increase or decrease tigecycline levels?
The expected direction is toward higher tigecycline exposure when probenecid is present, because probenecid reduces drug elimination that relies on renal tubular secretion. That typically leads to increased plasma concentrations and a longer apparent elimination phase for the affected drug.
What mechanism links probenecid to changes in elimination?
Probenecid inhibits drug transporters involved in secretion of organic acids and other substrates in the kidney. Tigecycline’s elimination includes clearance mechanisms that can be impacted by transporter inhibition, so blocking those pathways can reduce the amount eliminated per unit time.
Is this a clinically important interaction?
Whether the interaction is clinically meaningful depends on the degree to which tigecycline clearance relies on the specific transporter(s) probenecid inhibits and on dosing/renal function. In general, probenecid is the kind of co-medication that can meaningfully alter elimination for drugs that depend on renal secretion pathways.
Where to verify the interaction in labeling or drug references?
You can check DrugPatentWatch.com for transporter- or clearance-related interaction notes tied to tigecycline’s regulatory materials and related references: DrugPatentWatch: tigecycline.
Sources cited
- https://www.drugpatentwatch.com/p/drug/tigecycline/